Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk

Prolonged estrogen exposure is believed to be the major cause of endometrial cancer. As possible markers of estrogen exposure, various menstrual and reproductive features, e.g., ages at menarche and menopause, are found to be associated with endometrial cancer risk. In order to assess their combined effects on endometrial cancer, we created the total number of menstrual cycles (TNMC) that a woman experienced during her life or up to the time of study and two genetic risk scores, GRS1 for age at menarche and GRS2 for age at menopause. Comparing 482 endometrial cancer patients with 571 population controls, we found TNMC was associated with endometrial cancer risk and that the association remained statistically significant after adjustment for obesity and other potential confounders. Risk increased by about 2.5% for every additional 10 menstrual-cycles. The study also showed that high GRS1 was associated with increased risk. This relationship, however, was attenuated after adjustment for obesity. Our study further indicated women with high TNMC and GRS1 had twice the risk of endometrial cancer compared to those low in both indices. Our results provided additional support to the involvement of estrogen exposure in endometrial cancer risk with regard to genetic background and lifestyle features.

[1]  D. Gudbjartsson,et al.  Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche , 2009, Nature Genetics.

[2]  Y. Okada,et al.  Genome Wide Association Study of Age at Menarche in the Japanese Population , 2013, PloS one.

[3]  F. Clavel-Chapelon.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women , 2002, Cancer Causes & Control.

[4]  C. Friedenreich,et al.  Genome-wide association study of endometrial cancer in E2C2 , 2013, Human Genetics.

[5]  B. Henderson,et al.  Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort , 2010, International journal of cancer.

[6]  H. Adami,et al.  Overweight as an avoidable cause of cancer in Europe , 2001, International journal of cancer.

[7]  R. Kaaks,et al.  Obesity , Endogenous Hormones , and Endometrial Cancer Risk : A Synthetic Review 1 , 2002 .

[8]  D. Grobbee,et al.  Postmenopausal Breast Cancer Risk and Cumulative Number of Menstrual Cycles , 2005, Cancer Epidemiology Biomarkers & Prevention.

[9]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[10]  B. Henderson,et al.  No Association of Risk Variants for Diabetes and Obesity with Breast Cancer: The Multiethnic Cohort and PAGE Studies , 2011, Cancer Epidemiology, Biomarkers and Prevention.

[11]  P. Ridker,et al.  Genome-wide association studies identify novel loci associated with age at menarche and age at natural menopause , 2009, Nature Genetics.

[12]  C. Friedenreich,et al.  Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition , 2007, Cancer Causes & Control.

[13]  X. Shu,et al.  Weight history and risk of endometrial cancer among Chinese women. , 2006, International journal of epidemiology.

[14]  Jong-Young Lee,et al.  Genome-wide association studies and epistasis analyses of candidate genes related to age at menarche and age at natural menopause in a Korean population , 2014, Menopause.

[15]  C. la Vecchia,et al.  Reproductive factors and risk of endometrial cancer. , 1991, American journal of obstetrics and gynecology.

[16]  E. Demerath,et al.  Meta-analysis of genome-wide association data identifies two loci influencing age at menarche , 2009, Nature Genetics.

[17]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[18]  F. Hsu,et al.  Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study , 2014, Diabetes Care.

[19]  Sabina Rinaldi,et al.  The European Prospective Investigation into Cancer and Nutrition biobank. , 2011, Methods in molecular biology.

[20]  S. Levy,et al.  Genome-Wide Association Analyses Identify SPOCK as a Key Novel Gene Underlying Age at Menarche , 2009, PLoS genetics.

[21]  M. Pike,et al.  Type I and II endometrial cancers: have they different risk factors? , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  X. Shu,et al.  Menstrual and reproductive factors and endometrial cancer risk: Results from a population‐based case‐control study in urban Shanghai , 2004, International journal of cancer.

[23]  R. Goldbohm,et al.  Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. , 2004, Journal of the National Cancer Institute.

[24]  Ivar Heuch,et al.  Reproductive factors and risk of cancer of the uterine corpus: a prospective study. , 1988, Cancer research.

[25]  Hilary O D Critchley,et al.  Endocrine regulation of menstruation. , 2006, Endocrine reviews.

[26]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[27]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[28]  P. Hartge,et al.  Lifetime Weight History and Endometrial Cancer Risk by Type of Menopausal Hormone Use in the NIH-AARP Diet and Health Study , 2007, Cancer Epidemiology Biomarkers & Prevention.

[29]  K. Hemminki,et al.  Endometrial cancer: population attributable risks from reproductive, familial and socioeconomic factors. , 2005, European journal of cancer.

[30]  M. Beckmann,et al.  Genome-wide association study identifies a common variant associated with risk of endometrial cancer , 2011, Nature Genetics.

[31]  T. Key,et al.  Energy balance and cancer: the role of sex hormones , 2001, The Proceedings of the Nutrition Society.

[32]  S. Mayne,et al.  Long‐term overweight and weight gain in early adulthood in association with risk of endometrial cancer , 2011, International journal of cancer.

[33]  E. Demerath,et al.  Reproductive aging-associated common genetic variants and the risk of breast cancer , 2012, Breast Cancer Research.

[34]  Molly Fox,et al.  Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women , 2013, Psychoneuroendocrinology.

[35]  P. Kraft,et al.  Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976–2004 , 2010, International journal of cancer.

[36]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[37]  Yan V. Sun,et al.  Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways , 2012, Nature Genetics.

[38]  R. Kaaks,et al.  Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.

[39]  T. Sellers,et al.  Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study. , 1996, American journal of epidemiology.

[40]  L. Lipworth,et al.  A case-control study of endometrial cancer in relation to reproductive, somatometric, and life-style variables. , 1996, Oncology.

[41]  Martin Eklund,et al.  Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study. , 2011, European urology.

[42]  F. Clavel-Chapelon,et al.  Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition , 2010, International journal of cancer.

[43]  Christian Gieger,et al.  Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies , 2010, Nature Genetics.

[44]  R. Kurman,et al.  The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients , 1986 .

[45]  A. Hofman,et al.  Loci at chromosomes 13, 19 and 20 influence age at natural menopause , 2009, Nature Genetics.

[46]  I. Torres-Aleman,et al.  The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. , 2004, European journal of pharmacology.